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Abstract In lower rectal cancer, postoperative outcome is
still subject of controversy between the advocates of
abdominoperineal resection (APR) and low anterior resection
(LAR). Reports suggest that low anterior resection may be
oncologically superior to abdominoperineal excision, al-
though no good evidence exists to support this. Publications
were identified which assessed the differences comparing 5-
year survival, local recurrence, circumferential resection mar-
gin rate, complications and so on. A meta-analysis was per-
formed to clarify the safety and feasibility of the two proce-
dures with several types of outcome measures. A total of 13
studies met the inclusion criteria, and comprised 6,850 cases.
Analysis of these data showed that LAR group was highly
correlated with 5-year survival (pooled OR=1.73, 95%CI:
1.30–2.29, P=0.0002 random-effect). And local recurrence
rate of APR group was significantly higher than that in LAR
group (pooled OR=0.63, 95%CI: 0.53–0.75, P<0.00001
fixed-effect). Also, the circumferential resection margin
(CRM) were high involved in APR group than in LAR group.
(5 trials reported the data, pooled OR=0.43, 95%CI: 0.36–
0.52, P<0.00001 fixed-effect). Besides, the incidents of over-
all complications of APR group was higher compared with
LAR group (pooled OR=0.52, 95%CI: 0.29–0.92, P=0.03
random-effect). Patients treated by APR have a higher rate of
CRM involvement, a higher local recurrence, and poorer
prognosis than LAR. And there is evidence that in selected
low rectal cancer patients, LAR can be used safely with a
better oncological outcome than APR. due to the inherent
limitations of the present study, for example, the trails avail-
able for this systematic review are limited and the finite
retrospective data, future prospective randomized controlled
trials will be useful to fully investigate these outcome mea-
sures and to confirm this conclusion.
Keywords Low anterior resection . Abdominoperineal
resection . Lower rectal cancer . Prognosis
Background
Colorectal carcinoma is the fourth most common malignancy
worldwide. The major sphincter-saving operation (SSO) low
anter ior resect ion (LAR) is more common than
abdominoperineal resection (APR) in the treatment of rectal
cancer. rectal cancer patients preferred LAR to APR as it
avoided the requirement for a permanent stoma, despite the
fact that LAR was associated with a risk of postoperative
complications including fecal incontinence [1]. APR are
therefore considered only where sphincter-preserving LAR
are not feasible, or only when the tumor is fixed to the anal
sphincter or is less than 1 cm above the anal sphincter [2].
Most studies have reported an APR to LAR ratio of 1:3 or 1:4
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[3, 4], suggesting that LAR may be oncologically superior to
APR [5]. A number of studies comparing the short-term or
long-term outcomes, of LAR vs APR for lower rectal cancer
have shown that LAR has become the preferred option in
curative surgery [6–9]. Patients treated by APR have a higher
rate of circumferential margin involvement, a higher local
recurrence, and poorer prognosis than LAR [10–12]. Howev-
er, most studies were too small to adequately evaluate the
surgical outcomes. For those patients with lower rectal cancer
eligible for surgical treatment, whether APR or LAR is the
better choice remains controversial [13–15]. Therefore, this
article has prompted the present comparison of the operative
results and oncologic outcomes of those patients treated by
LAR and APR. We performed a meta-analysis of all the
studies directly comparing APR and LAR in the treatment of
low rectal cancer. these results may help to determine that the
selected surgical procedure, either LAR of APR, is performed
safely.
Materials and Methods
Information Sources and Search
A systematic literature search was performed independently
by two of the authors (FBK and XTW) using Medline,
Embase, BioMed Central, CNKI (Chinese National Knowl-
edge Infrastructure Database), Wangfang (Database of Chi-
nese Ministry of Science & Technology), and CBM (China
Biological Medicine Database) and performed on all studies
for potentially relevant records comparing APR and LAR.
The search was limited to humans. Animal trials were be
excluded. No restriction was set for date of publication.
FBK and XTW assessed titles or abstracts of all identified
studies independently and exclude all the irrelevant ones. Full
text articles of potentially relevant studies were obtained.
These studies were assessed independently in an unblended
standardized manner by FBK and XTW as to whether they
met the inclusion criteria for this review.
Combinations of the following search terms were be used:
“abdominoperineal resection”; “low anterior resection”; “co-
lon” or “rectum”; “cancer”, “neoplasia” or “tumor”.
To minimize retrieval bias we performed a manual search
method that utilize the Google Scholar database, Science
Citation Index, Cochrane Library, and manually searched
seven high-impact journals, chosen on the basis of the fre-
quency of articles and on expert opinion. When further infor-
mation was required, the corresponding authors of relevant
papers were contacted by the authors (FBK and XTW). The
reference lists of all potentially eligible studies will be
reviewed. Researchers who may have carried out relevant
studies will be contacted.
Inclusion Criteria
The following criteria were fulfilled for the studies included in
the meta-analysis: (1) trials had to be published as a full paper
in English or Chinese language literature. (2) The studies
compared the original outcomes of LAR and APR in the
treatment of patients with low rectal cancer within 6 cm of
the anal verge; (3) no preoperative radiotherapy, chemothera-
py, and/or neoadjuvant chenoradiation administered to the
patients; (4) the patients’ clinical and pathologic parameters
(age, sex, tumor differentiation, TNM classification, margin
status and so on) must be mentioned in article. (5) If more than
one studies were reported by the same institute or author, only
the most recent or the highest level of studies were included.
Exclusion Criteria
The following studies were excluded: (1) The inclusion
criteria were not met; (2) with operation contraindication; (3)
The research samples were too small and the cases were less
than 20 cases; (4) there was no initial data or cannot search
original literatures; (5) the original studies only assessing
outcome of either LAR or APR; (6) the patients accepted
other treatment before or after surgery and these treatments
could lead to distinct prognosis; (7) review articles, letters,
comments, case reports.
Data Extraction
Data extraction was performed independently by two of the
authors (KFB andWXT). Disagreements were solved through
discussion, if necessary, by involving an independent third
author(LMP). The main extracted data included: (1) First
author and the year of publication, (2) The number and char-
acteristics of trial participants, (3) institution, study design,
inclusion and exclusion criteria, matching criteria, sample size
(cases and controls or cohort size). (4) The outcome of the
trials including the 5-year survival and local recurrence plus
overall complications. (5) We made an effort to contact all
primary authors of studies by e-mail to standardize their data
according to the meta-analysis definitions whenever possible,
and in all cases of missing or incomplete data, the primary
authors were contacted for original information, but none
provided any additional information.
Results
Description of Eligible Studies
Using the search strategy described above and excluding
duplicates, 192 publications were identified. One
20 X.-T. Wang et al.
hundred and seventy three studies were excluded fol-
lowing title and abstract review. Five further studies
were excluded after evaluation of the full-text in detail
in full. This literature search identified 14 studies that
compared the results of LAR and APR for rectal cancer.
Of these, one study was excluded from the analysis
because it did not provide adequate results for the
outcomes of interest. This left 13 studies, which ful-
filled the inclusion criteria and formed the basis of this
review (Tables 1 and 2). On view of the data extraction,
there was 100 % agreement among the three reviewers.
These included a combined total of 6,850 subjects, of
which 3,866 (56.44 %) underwent LAR and 2,984
(43.56 %) underwent APR as the primary operative
intervention for rectal cancer. Two studies [6, 15]
contained groups that were fully matched for age and
sex, whereas eleven studies [5, 7–12, 16–19] had groups
matched for age, sex, comorbidity, physical condition
factors (BMI), and tumor stage. The matching was also
performed in terms of demographic data, tumor charac-
teristics, operative data, and postoperative outcomes
(Fig. 1).
Overall Survival
As Fig. 2a shows, eleven studies evaluated 5-year survival rate
after operation [5, 6, 8, 9, 11, 12, 15–19]. The statistic data
was significantly favorable to LAR group at 5-year survival
(pooled OR=1.73, 95%CI: 1.30–2.29, P=0.0002 random ef-
fect) (χ2=47.73, df=10, P<0.00001, I2=79 %) (Fig. 2a).
Only Nagtegaal et al. [5] (57.6 % versus 38.5 %; P=0.008)
showed a better outcome in the APR group.
Local Recurrence Rate and CRM Rate After Operation
Ten studies evaluated local recurrence rate after opera-
tion [5, 6, 8, 9, 11, 12, 15–17, 19], results of the
pooled analysis showed that local recurrence rate of
APR group was significantly higher than that in LAR
group (pooled OR=0.63, 95%CI: 0.53–0.75, P<0.00001
fixed-effect). The results of homogeneity test showed
that χ2=16.70, df=9, P=0.05, I2=46 %. The circumfer-
ential resection margin (CRM) were high involved in
APR group than in LAR group. (5 trials reported the
data, pooled OR=0.43, 95%CI: 0.36–0.52, P<0.00001
fixed-effect) (χ2=7.56, df=4, P=0.11, I2=47 %) (Fig 2b
and c).
Overall Complications
It was not possible to compare the urinary retention in
the included studies. The reason is that only Campos-
Lobato et al. [10] and Kim et al. [12] reported these
outcomes in the full article published in 2011 and 2012
respectively. The overall incidence of surgical complica-
tions was available, including hemorrhage, ureter injury,
bladder injury, and anastomotic rupture. Seven studies
reported overall complications [5, 8, 10–12, 17, 19], the
results of homogeneity test showed that there was a
significant heterogeneity (χ2=34.84, df=6, P<0.00001,
I2=83 %) and adopted random-effects model to analyze.
Results of the pooled analysis showed that the incidents
of overall complications of APR group was higher com-
pared with LAR group (pooled RR=0.52, 95%CI: 0.29–
0.92, P=0.03 random-effect) (Fig. 2d).
Table 1 Study characteristics for the included studies
Study ID Study setting Total no. of patients Age (range) Male: female
LAR group APR group LAR group APR group LAR group APR group
Chambers 2010 [8] United kingdom 93 70 67.1 (38.4–86.4) 63.5 (32–83.4) 69:24 39:31
Chuwa 2006 [11] Singapore 677 93 65 (22–89) 64 (33–93) 392:285 52:41
He 2002 [18] China 128 356 41.6 (27–61) 58 (35–84) 72:56 214:142
Heald 1997 [16] United kingdom 105 31 62.7 (27–97) 62.7 (27–97) NS NS
Kim 2012 [12] South Korea 402 402 54 (45–63) 54 (44–64) 238:164 237:165
Law 2001 [17] Hong Kong 123 57 63.6 (25–83) 65.0 (26–86) 71:52 36:21
Li 2006 [6] China 244 355 NS NS 125:119 197:158
Li 2009 [19] China 53 25 61 (35–79) 65 (43–75) 31:26 19:9
Marr 2005 [9] United kingdom 355 181 NS NS NS NS
Nagtegaal 2005 [5] United kingdom 205 453 63.9 (27–85) 64.6 (25–87) 97:108 254:199
Wibe 2004 [15] Norway 1,315 821 NS NS 859:456 478:343
Shihab 2010 [7] United kingdom 81 72 67.3 64.8 54:27 51:21
Campos-Lobato 2011 [10] USA 85 68 55 (45–61) 63 (54–74) 23:27 26:38
NS Not stated, LAR Low anterior resection APR Abdominoperineal resection
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Publication Bias
The Funnel plot recommended for meta-analyses did not
show an asymmetrical pattern (Fig. 3), indicating a publica-
tion bias did not exist. Besides, an influence analysis was used
to evaluate the influence of single study on the summary
effect. The meta-analysis was not dominated by any individ-
ual study, and removing any study at a time made no
difference.
Discussion
Abdominoperineal resection (APR) was first described by sir
W. Ernest Miles in 1908 [20]. For a century, it had been the
gold standard for all cancers of the lower third and bulky
tumors of the middle third of the rectum. However, there were
significant numbers of patients who do not agree to the treat-
ment with permanent iliac colostomy. Facing the challenge of
the physical, psychological consequences of a permanent iliac
colostomy from those patients, majority of surgeons tried to
develop procedures to save the lower end. The concept of total
mesorectal excision (TME) and the increasing use of stapling
devices for rectal and anal anastomoses have had a significant
impact on the treatment of distal cancer. With the use of TME
and a close distal resection margin, the need for sphincter
ablation can be reduced. Although APR has been described
as standard treatment for tumors less than 8 cm from the anal
verge, more patients with distal rectal cancer are now being
treated with sphincter-saving surgery. Low anterior resection
(LAR) with straight coloanal anastomosis gained wide accep-
tance in the treatment of the cancer of lower third of the
rectum. With the advent of stapling instruments and the tech-
niques such as transanal coloanal anastomosis, the incidence
of APR is reduced by 50 %.
For those patients with lower rectal cancer eligible for
surgical treatment, whether APR or LAR is the better choice
remains controversial. In a study of 608 rectal cancer patients
by Marr et al. [9]. APR was associated with greater local
recurrence and a lower 5-year survival rate compared with
LAR [9]. Two studies reported that the incidence of CRM
involvement in APR was more than threefold greater than in
LAR [5, 9]. To avoid CRM involvement, Holm et al. recom-
mend an extended APR, which includes en bloc excision of
the levator muscles with the anus and the lower rectum [21].
However, another reasearch showed that the oncologic out-
comes of patients treated by APR are not worse than those
treated by LAR [11]. Kim and colleagues indicated that APR
can be used safely without impairing oncological outcome
when performed with appropriate skill to achieve R0 resection
[12]. These conflicting results were likely due to small sample
size of the study. Meta-analysis was originally developed to
combine the results of randomized controlled trails, and re-
cently this approach has been applied successfully for identi-
fication of prognostic indicators in patients with malignant
diseases [22–24].
This meta-analysis is the first study to systematically esti-
mate the technical feasibility, effectiveness, and safety of APR
and LAR in the treatment of lower rectal cancer, through a
systematic review of published comparative studies. The re-
sults of this meta-analysis indicated that APR led to worse
cancer specific outcome than LAR. In other words, APR
group could not increase 5-year survival rate and reduce
operative complications compared with LAR, in keeping with
other published results [16].
Table 2 quality assessment of













Chambers 2010 [8] Unclear Unclear Unclear Yes Unclear Unclear
Chuwa 2006 [11] Unclear Yes Unclear Yes Yes Yes
He 2002 [18] Yes Yes Unclear Yes Yes Unclear
Heald 1997 [16] Yes Unclear Unclear Yes Unclear Yes
Kim 2012 [12] Yes Yes Unclear Yes Yes Yes
Law 2001 [17] Yes Yes Unclear Yes Yes Yes
Li 2006 [6] Yes Yes Unclear Yes Yes Yes
Li 2009 [19] Yes Yes Unclear Yes Yes Yes
Marr 2005 [9] Unclear Yes Unclear Yes Yes Unclear
Nagtegaal 2005 [5] Yes Yes Unclear Yes Yes Unclear
Wibe 2004 [15] Yes Unclear Unclear Yes Unclear Yes
Shihab 2010 [7] Yes Yes Unclear Yes Yes Yes
Campos-Lobato
2011 [10]
Yes Yes Unclear Yes Yes Yes
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The tumors were lower and larger in the APR group,
although the patients in the LAR and APR groups were
comparable in terms of age, tumor stage, and neoadjuvant
treatment. The distribution of tumor stage within the APR
and LAR groups was similar for both patient, however, it
would not be possible to avoid this bias as bigger tumors
would tend to undergo an APR, as sphincter saving would
not be attempted. The extent of tumor spread in itself is
therefore unlikely to account for the increased CRM involve-
ment, increased local recurrence, and poor survival in the APR
group [9].
Circumferential resection margin (CRM) involvement is a
strong prognostic indicator for local recurrence. The patients
who underwent APR had a significantly higher incidence of
circumferential margin involvement, which is associated with
both local recurrence and poor survival. There is evidence to
suggest that APR is associated with a higher CRM involve-
ment rate, which has been found to be an acceptable surrogate
endpoint for increased local recurrence and lower patient
survival [25]. CRM involvement increases the more distally
the tumor is located [26]. One analysis [27] showed that CRM
is of prognostic value for both local recurrence and overall
survival in patients treated with an APR, similar to previously
published results demonstrating the importance of CRM for
all patients [26]. It can be concluded that the poor prognosis of
APR was attributable to frequent CRM involvement. Possible
reasons include higher incidence of inadequate excision in
APR, or that lymph node involvement may follow a different
pattern in low rectal carcinomas. Furthermore, distance from






Potentially relevant studies identified
(n=210)
Potentially appropriate records to be included
(n=192)












Studies included in qualitative synthesis
(n=13)
10 articles published in English






Fig. 1 Flowchart of the search
process
Abdominoperineal resection versus low anterior resection for lower rectal cancer 23
24 X.-T. Wang et al.
excision. Just as how chuwa et al. [11] had pointed out that
only 37 %of the patients whose tumors were located 5 cm or
less from the anal verge had complete mesorectal excision,
because of the greater difficulty of performing a perfect TME
low down in the pelvis. And TME cannot always be per-
formed down to the levators in APR because of the presence
of a large tumor around this level. The frequency of CRM
involvement for APR has not diminished with TME. CRM
involvement in the APR specimens is related the removal of
less tissue at the level of the tumor in an APR [9]. The poor
prognosis of the patients with an APR is ascribed to the
resection plane of the operation leading to a high frequency
of margin involvement by tumor and perforation with this
current surgical technique [26].
Local recurrence is an important indicator of the success of
rectal surgery. The high rates of local recurrence of APRs
could be explained by a number of factors either singly or in
combination. Although there is convincing evidence that
TME reduces local recurrence rates by 1–6 % [9], APR may
be associated with a different pattern of lymphatic spread,
which is not included in the “tumor package” excised by
TME, or inadequate surgical resection may occur in a higher
proportion of patients. Inadequate excision appears to be the
major factor determining outcome, but APR, the form of more
radical surgery, may not improve the current situation of high
local recurrences and poorer survival.
Despite important progress made in the past decade
regarding techniques and perioperative management, pa-
tients with rectal cancer still inevitably experience surgical
complications. The commonest complication of APR was
perineal wound failure, and anastomotic leak was the
commonest complication after LAR [8]. With the lowering
level of colo-anal anastomosis and increasing demands for
anal-sphincter preservation, risks such as anastomotic leak-
age and hemorrhage are considered to be the major com-
plications of LAR. And Jorge et al. [28] reported a
leakage rate of 11-12 % following rectal cancer surgery.
However, we have demonstrated that the postoperative
complications such as pelvic abscess, voiding difficulty,
sexual dysfunction, erectile dysfunction and ejaculatory
dysfunction, is more higher in the APR group than in
the LAR group. Besides, only 20.9 % of patients in the
APR group satisfied with the permanent stoma [12]. Pa-
tients undergoing APR do have some restriction in their
postoperative QoL, such as body image, which can be
severely disruptive to their social life. The results of
meta-analysis indicated that the incidence of LAR compli-
cations was higher compared with APR group. These data
are in line with the incidence reported in literature.
Sphincter-preserving surgery must be considered the
primary procedure of choice, LAR can be safely used in
patients with proper technique without impairing onco-
logical outcome, Although an APR is necessary in
many patients with low or advanced tumors and cannot
be substituted with an LAR.
Fig. 2 Forest plot of RR for 5-year survival, local recurrence, CRM and
complication among included studies. A. results of the meta-analysis on
5-year survival. B. results of the meta-analysis on local recurrence. C.
results of the meta-analysis on CRM. D. results of the meta-analysis on
complication
Fig. 3 Funnel plot of studies to
detect publication bias
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Certain limitations in the present meta-analysis need to be
pointed out. First, this meta-analysis contain only retrospec-
tive data, all the studies included were observational, and the
small number of cases in several studies also decreased the
reliability of the results, which made it difficult to acquire
strong evidence for the conclusions. Although we compared
the study groups with respect to all variables known to affect
the primary outcome, there are certainly confounders and
variables unaccounted for that may affect the results. There
is a conspicuous absence of prospective randomized trials in
this subject area, which should be addressed in future re-
search. Second, the studies included in the analysis were
mostly conducted at major institutions. Therefore, the patients
evaluated might not reflect patient populations in the commu-
nity. In other words, the evaluation of data coming from high
volume centers might not represent the real world. Third,
heterogeneity between studies was low for most of the dichot-
omous variables examined in this analysis, but was marked for
all the continuous variables. There was significant variability
in terms of definitions, inclusion criteria, exclusion criteria,
operating technique, andmeasurement of outcomes. It was not
possible to match all patient groups for age, BMI, tumor stage,
preoperative therapy, and previous abdominal history. All
these factors may have contributed to the high heterogeneity
between studies. Use of the RE model for pooled data might
minimize the effects of heterogeneity, but does not abolish
them. The degree of heterogeneity fell for most outcomes with
sensitivity analysis, but this difference was not significant.
Fourth, some perioperative data reported as median (range)
were calculated to reach the mean (SD) values with the
techniques introduced in literature [29], and it is considered
a limitation of the daa analysis in the current study. Fifth, we
excluded the patients accepted other treatment before and/ or
after surgery. However, preoperative radiotherapy, chemother-
apy, and/or neoadjuvant chemoradiation of advanced rectal
cancer could be potentially be useful for local control and
sphincter saving [30]. Finally, some authors did not report the
proportion of patients lost to follow-up, which may influence
the reliability of the conclusions. Therefore, we tried to opti-
mize standardization, but some remaining variability in defi-
nitions was unavoidable, and there were subtle differences in
assessment of primary outcomes between studies. We tried to
overcome this potential issue by defining low rectal cancer as
a distal tumor margin within 6 cm of the anal verge and by
including only those studies that included patient details that
allowed us to best apply our definitions.
The present meta-analysis suggests that LAR has a higher
5-year survival rate, low CRM rate, local recurrence and
complications rate than APR. in selected low rectal cancer
patients, LAR is a better option than APR. Despite our rigor-
ous methodology, the inherent limitations of the included
studies should be considered, and conclusions drawn from
our pooled results should be interpreted with caution. Future
prospective, multicentre, and randomized trials including
small number of cases, preoperative radiotherapy, chemother-
apy, and/or neoadjuvant chemoradiation administered to the
patients will be useful to confirm this conclusion.
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